HealthEquity (NASDAQ:HQY) Updates FY25 Earnings Guidance

HealthEquity (NASDAQ:HQY) updated its FY25 earnings guidance on Tuesday. The company provided earnings per share guidance of $2.79-2.96 for the period, compared to the consensus earnings per share estimate of $2.86. The company issued revenue guidance of $1.14-1.16 billion, compared to the consensus revenue estimate of $1.15 billion.

Analysts Set New Price Targets

Several research firms have weighed in on HQY. Barrington Research restated an outperform rating and set a $85.00 target price on shares of HealthEquity in a research note on Monday, December 4th. Raymond James increased their price target on HealthEquity from $90.00 to $95.00 and gave the company an outperform rating in a research note on Wednesday, December 13th. Royal Bank of Canada increased their price target on HealthEquity from $77.00 to $90.00 and gave the company an outperform rating in a research note on Friday, February 23rd. JPMorgan Chase & Co. dropped their price target on HealthEquity from $81.00 to $73.00 and set an overweight rating for the company in a research note on Friday, December 1st. Finally, Barclays increased their price target on HealthEquity from $84.00 to $104.00 and gave the company an overweight rating in a research note on Friday, February 23rd. One investment analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, HealthEquity presently has an average rating of Moderate Buy and a consensus target price of $87.38.

HealthEquity Trading Up 0.7 %

HealthEquity stock traded up $0.57 during trading hours on Tuesday, reaching $83.53. 734,140 shares of the company’s stock were exchanged, compared to its average volume of 598,828. The company has a quick ratio of 4.93, a current ratio of 4.93 and a debt-to-equity ratio of 0.44. The firm’s 50 day simple moving average is $78.54 and its 200 day simple moving average is $72.66. HealthEquity has a twelve month low of $48.86 and a twelve month high of $84.13. The firm has a market capitalization of $7.17 billion, a PE ratio of 244.00, a PEG ratio of 1.28 and a beta of 0.53.

Insider Activity

In related news, EVP Delano Ladd sold 2,586 shares of the firm’s stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $70.00, for a total value of $181,020.00. Following the transaction, the executive vice president now owns 52,495 shares of the company’s stock, valued at approximately $3,674,650. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders sold a total of 7,643 shares of company stock worth $592,205 in the last three months. Company insiders own 2.70% of the company’s stock.

Hedge Funds Weigh In On HealthEquity

Several hedge funds have recently modified their holdings of HQY. PNC Financial Services Group Inc. lifted its position in shares of HealthEquity by 31.8% during the 1st quarter. PNC Financial Services Group Inc. now owns 13,547 shares of the company’s stock worth $913,000 after buying an additional 3,266 shares in the last quarter. AlphaCrest Capital Management LLC bought a new position in shares of HealthEquity during the 1st quarter worth approximately $234,000. Natixis Advisors L.P. bought a new position in shares of HealthEquity during the 1st quarter worth approximately $932,000. Bank of Montreal Can lifted its position in shares of HealthEquity by 44.5% during the 1st quarter. Bank of Montreal Can now owns 8,218 shares of the company’s stock worth $553,000 after buying an additional 2,532 shares in the last quarter. Finally, Rhumbline Advisers lifted its position in shares of HealthEquity by 2.2% during the 1st quarter. Rhumbline Advisers now owns 231,307 shares of the company’s stock worth $15,599,000 after buying an additional 4,880 shares in the last quarter. Institutional investors own 98.46% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.